113 related articles for article (PubMed ID: 38615271)
21. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D receptor rs3782905 and vitamin D binding protein rs7041 polymorphisms are associated with hepatocellular carcinoma susceptibility in cirrhotic HCV patients.
El-Masry AS; Medhat AM; El-Bendary M; Mohamed RH
BMC Med Genomics; 2023 Dec; 16(1):319. PubMed ID: 38066559
[TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
24. Significant association between FasL gene -844T/C polymorphism and risk to hepatocellular carcinoma in Egyptian patients.
Khalifa RH; Bahgat DM; Darwish HA; Shahin RM
Immunol Lett; 2016 Apr; 172():84-8. PubMed ID: 26891954
[TBL] [Abstract][Full Text] [Related]
25. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
Zhang QX; Li SL; Yao YQ; Li TJ
Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
[TBL] [Abstract][Full Text] [Related]
26. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
[TBL] [Abstract][Full Text] [Related]
27. COX-2 polymorphisms -765G→C and -1195A→G and hepatocellular carcinoma risk.
Gharib AF; Karam RA; Abd El Rahman TM; Elsawy WH
Gene; 2014 Jun; 543(2):234-6. PubMed ID: 24720952
[TBL] [Abstract][Full Text] [Related]
28. Association between Genetic Polymorphisms in MicroRNAs 196a2 (rs11614913) and 34 b/c (rs4938723) and Risk of Hepatocellular Carcinoma in Egyptian Patients.
Ibrahim AA; El-Feki MA; Gamal M; Doudar NA; Marey H; Abd El Ghany WM; Abdalla NH
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1373-1377. PubMed ID: 35485699
[TBL] [Abstract][Full Text] [Related]
29. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population.
Xie Q; Chen Z; Xia L; Zhao Q; Yu H; Yang Z
Gene; 2018 Oct; 674():188-194. PubMed ID: 29940275
[TBL] [Abstract][Full Text] [Related]
30. Association between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical Progression.
Lau HK; Hsieh MJ; Yang SF; Wang HL; Kuo WH; Lee HL; Yeh CB
Int J Med Sci; 2016; 13(7):556-61. PubMed ID: 27429592
[TBL] [Abstract][Full Text] [Related]
31. Association study of single nucleotide polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in Chinese Han population.
Bi J; Zhong C; Li K; Chu H; Wang B
Biomed Res Int; 2013; 2013():138785. PubMed ID: 23984316
[TBL] [Abstract][Full Text] [Related]
32. MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primary hepatocellular carcinoma receiving interventional therapy.
Hu W; Huang S; Dong L; Yu C; Li C; Zhang J
Anticancer Drugs; 2019 Mar; 30(3):233-240. PubMed ID: 30779721
[TBL] [Abstract][Full Text] [Related]
33. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
34. Impact of FOXP1 rs2687201 genetic variant on the susceptibility to HCV-related hepatocellular carcinoma in Egyptians.
Motawi TMK; Sabry D; Shehata NI; William MM; Fahim AT
J Biochem Mol Toxicol; 2022 Mar; 36(3):e22965. PubMed ID: 34783112
[TBL] [Abstract][Full Text] [Related]
35. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.
Shin SP; Kim NK; Kim JH; Lee JH; Kim JO; Cho SH; Park H; Kim MN; Rim KS; Hwang SG
World J Gastroenterol; 2015 Dec; 21(46):13064-72. PubMed ID: 26672513
[TBL] [Abstract][Full Text] [Related]
36. Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development.
Hsieh MC; Hsu HT; Hsiao PC; Yang SF; Yeh CB; Bien MY; Lin CH; Chien MH
J Clin Lab Anal; 2014 May; 28(3):237-44. PubMed ID: 24478168
[TBL] [Abstract][Full Text] [Related]
37. XRCC1 Gene Polymorphism Increases the Risk of Hepatocellular Carcinoma in Egyptian Population.
Naguib M; Helwa MM; Soliman MM; Abdel-Samiee M; Eljaky AM; Hammam O; Zaghla H; Abdelsameea E
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1031-1037. PubMed ID: 32334466
[TBL] [Abstract][Full Text] [Related]
38. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
ELBassuoni MA; Abd El Fatah G; Zaghla H
Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
[TBL] [Abstract][Full Text] [Related]
39. Association of MTHFR and TYMS gene polymorphisms with the susceptibility to HCC in Egyptian HCV cirrhotic patients.
Abdel Allah HMM; Zahran WE; El-Masry SA; El-Bendary M; Soliman AF
Clin Exp Med; 2022 May; 22(2):257-267. PubMed ID: 34297238
[TBL] [Abstract][Full Text] [Related]
40. The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility.
Junjie X; Songyao J; Minmin S; Yanyan S; Baiyong S; Xiaxing D; Jiabin J; Xi Z; Hao C
BMC Cancer; 2012 Feb; 12():57. PubMed ID: 22309608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
